Galmed Pharmaceuticals Ltd. (GLMD)

NASDAQ: GLMD · Real-Time Price · USD

Compare

0.6700

+0.0046 (0.69%)

At close: Feb 3, 2026, 4:00 PM EST

0.7000

+0.0300 (4.48%)

After-hours: Feb 3, 2026, 5:09 PM EST

Galmed Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	3.31	4.65	2.86	2.02	2.88	6.95
Short-Term Investments	15.74	10.68	9.78	11.77	31.93	43.94
Cash & Short-Term Investments	19.05	15.33	12.64	13.79	34.82	50.89
Cash Growth	11.15%	21.27%	-8.29%	-60.41%	-31.58%	-32.59%
Other Receivables	0.55	0.21	0.17	0.16	0.08	0.07
Receivables	0.55	0.21	0.17	0.16	0.08	0.07
Prepaid Expenses	-	0.46	0.32	0.67	1.05	0.75
Restricted Cash	0.12	0.12	0.12	0.11	0.11	0.11
Total Current Assets	19.72	16.12	13.24	14.72	36.05	51.81
Property, Plant & Equipment	-	-	0.13	0.34	0.55	0.57
Long-Term Investments	1.59	2.12	3.27	1.5	-	-
Total Assets	21.58	18.5	16.63	16.56	36.61	52.38
Accounts Payable	1.67	1.31	1.88	2.56	4.87	7.05
Accrued Expenses	-	0.86	0.83	-	-	-
Current Portion of Leases	-	-	0.04	0.17	0.21	0.2
Other Current Liabilities	0.8	0.01	-	0.36	0.8	0.76
Total Current Liabilities	2.47	2.17	2.75	3.09	5.88	8.01
Long-Term Leases	-	-	-	0.04	0.23	0.22
Total Liabilities	2.47	2.17	2.75	3.14	6.11	8.23
Common Stock	2.79	0.74	0.21	0.07	0.07	0.06
Additional Paid-In Capital	222.6	216.47	207.08	200.14	198.77	179.53
Retained Earnings	-205.96	-200.47	-192.95	-186.04	-168.17	-135.71
Comprehensive Income & Other	-0.32	-0.42	-0.45	-0.75	-0.17	0.27
Shareholders' Equity	19.11	16.33	13.88	13.42	30.5	44.15
Total Liabilities & Equity	21.58	18.5	16.63	16.56	36.61	52.38
Total Debt	-	-	0.04	0.22	0.44	0.42
Net Cash (Debt)	19.05	15.33	12.6	13.57	34.38	50.47
Net Cash Growth	11.15%	21.66%	-7.13%	-60.53%	-31.88%	-32.84%
Net Cash Per Share	5.94	16.47	54.60	97.14	251.58	426.87
Filing Date Shares Outstanding	5.48	2.26	0.5	0.14	0.14	0.14
Total Common Shares Outstanding	5.48	1.66	0.42	0.14	0.14	0.12
Working Capital	17.25	13.95	10.49	11.63	30.18	43.8
Book Value Per Share	3.49	9.81	33.01	95.87	218.80	372.67
Tangible Book Value	19.11	16.33	13.88	13.42	30.5	44.15
Tangible Book Value Per Share	3.49	9.81	33.01	95.87	218.80	372.67
Machinery	-	0.79	0.79	0.79	0.79	0.79
Leasehold Improvements	-	0.24	0.24	0.24	0.23	0.22

Updated Nov 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q